- Home
- VANI vs VNRX Comparison
VANI vs VNRX Comparison
Compare VANI & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- VNRX
- Stock Information
- Founded
- VANI 1998
- VNRX N/A
- Country
- VANI United States
- VNRX United States
- Employees
- VANI N/A
- VNRX N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VANI Health Care
- VNRX Health Care
- Exchange
- VANI Nasdaq
- VNRX Nasdaq
- Market Cap
- VANI 69.9M
- VNRX 59.6M
- IPO Year
- VANI 2014
- VNRX N/A
- Fundamental
- Price
- VANI $1.20
- VNRX $0.63
- Analyst Decision
- VANI Strong Buy
- VNRX Strong Buy
- Analyst Count
- VANI 1
- VNRX 4
- Target Price
- VANI $3.00
- VNRX $4.17
- AVG Volume (30 Days)
- VANI 134.7K
- VNRX 154.8K
- Earning Date
- VANI 11-13-2024
- VNRX 11-14-2024
- Dividend Yield
- VANI N/A
- VNRX N/A
- EPS Growth
- VANI N/A
- VNRX N/A
- EPS
- VANI N/A
- VNRX N/A
- Revenue
- VANI N/A
- VNRX $1,285,827.00
- Revenue This Year
- VANI N/A
- VNRX $71,446.31
- Revenue Next Year
- VANI N/A
- VNRX N/A
- P/E Ratio
- VANI N/A
- VNRX N/A
- Revenue Growth
- VANI N/A
- VNRX 97.50
- 52 Week Low
- VANI $1.01
- VNRX $0.43
- 52 Week High
- VANI $7.80
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- VANI 43.85
- VNRX 48.89
- Support Level
- VANI $1.17
- VNRX $0.61
- Resistance Level
- VANI $1.23
- VNRX $0.65
- Average True Range (ATR)
- VANI 0.05
- VNRX 0.05
- MACD
- VANI 0.00
- VNRX 0.00
- Stochastic Oscillator
- VANI 31.58
- VNRX 38.10
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.